Immunovant Inc - Asset Resilience Ratio

Latest as of September 2019: 98.50%

Immunovant Inc (IMVT) has an Asset Resilience Ratio of 98.50% as of September 2019. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Immunovant Inc to assess the company's strategic physical and investment asset allocation.

Liquid Assets

$116.02 Million

Cash + Short-term Investments

Total Assets

$117.79 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Immunovant Inc's Asset Resilience Ratio has changed over time. See net asset quality index of Immunovant Inc to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Immunovant Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see IMVT market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$116.02 Million	98.5%
Total Liquid Assets	$116.02 Million	98.50%

Asset Resilience Insights

Very High Liquidity: Immunovant Inc maintains exceptional liquid asset reserves at 98.50% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Immunovant Inc Industry Peers by Asset Resilience Ratio

Compare Immunovant Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Cyclacel Pharmaceuticals Inc NASDAQ:CYCC	Biotechnology	-55.36%
Krystal Biotech Inc NASDAQ:KRYS	Biotechnology	23.06%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Immunovant Inc (None–None)

The table below shows the annual Asset Resilience Ratio data for Immunovant Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Immunovant Inc

NASDAQ:IMVT USA Biotechnology

Market Cap

$7.06 Billion

Market Cap Rank

#3260 Global

#1135 in USA

Share Price

$34.71

Change (1 day)

+3.27%

52-Week Range

$14.69 - $35.56

All Time High

$52.71